{
  "id": "CG-EX:CritAssess291",
  "type": "CriterionAssessment",
  "criterion": {
    "id": "SEPIO-CG:99027",
    "type": "Criterion",
    "label": "PM1",
    "description": "Located in a mutational hot spot and/or critical and well-established functional domain (e.g., active site of an enzyme) without benign variation",
    "defaultStrength": {
      "id": "SEPIO:0000216",
      "type": "EvidenceLineStrength",
      "label": "Pathogenic Moderate"
    },
    "comments": "Suggested that this rule is NOT appropriate for LOF variants.\nAlso, note that when the region of interest is a “well-established functional domain” then it’s not necessary to show through evidence that it is intolerant of benign missense variants.  However, when a mutational hotspot is being defined, then showing it does not have benign missense variants is important."
  },
  "variant": {
    "id": "CAR:CA123651",
    "type": "CanonicalAllele",
    "preferredCtxAllele": {
      "id": "CG-EX:CtxAll029",
      "type": "ContextualAllele",
      "relatedCanonicalAllele": "CanAll026",
      "alleleName": "NM_004333.4(BRAF):c.1789C>G"
    }
  },
  "outcome": {
    "id": "SEPIO:0000223",
    "type": "CriterionEvaluation",
    "label": "Met"
  },
  "evidenceLine": [
    {
      "id": "CG-EX:EvLn023",
      "type": "EvidenceLine",
      "evidenceItem": [
        {
          "id": "CG-EX:RegTyp043",
          "type": "RegionType",
          "region": {
            "id": "_b4457",
            "type": "SequenceLocation",
            "referenceSequence": {
              "id": "REFSEQ:NM_004333.4",
              "type": "ReferenceSequence",
              "accession": "NM_004333.4"
            },
            "start": 1803,
            "stop": 1921
          },
          "annotation": [
            {
              "id": "SEPIO:0000320",
              "type": "RegionAnnotation",
              "label": "functional region"
            }
          ],
          "description": "This region is exon 15 in the transcript, and codes the serine-threonine-protein kinase catalytic domain."
        },
        {
          "id": "CG-EX:RegAll382",
          "type": "RegionAlleles",
          "region": {
            "id": "_b4457",
            "type": "SequenceLocation",
            "referenceSequence": {
              "id": "REFSEQ:NM_004333.4",
              "type": "ReferenceSequence",
              "accession": "NM_004333.4"
            },
            "start": 1803,
            "stop": 1921
          },
          "allele": [
            {
              "id": "CG-EX:CtxAll029",
              "type": "ContextualAllele",
              "relatedCanonicalAllele": "CanAll026",
              "alleleName": "NM_004333.4(BRAF):c.1789C>G"
            }
          ],
          "outcome": {
            "id": "RO:0002656",
            "type": "RegionAllelesOutcome",
            "label": "overlaps region"
          },
          "description": "This region is exon 15 in the transcript, and codes the serine-threonine-protein kinase catalytic domain."
        }
      ]
    }
  ],
  "contribution": [
    {
      "type": "Contribution",
      "agent": {
        "id": "CG-EX:Agent001",
        "type": "Agent",
        "label": "Harry Stevenson"
      },
      "contributionDate": "6/6/16 10:53 AM",
      "contributionRole": {
        "id": "SEPIO:0000154",
        "type": "ContributoryRole",
        "label": "assessor role"
      }
    },
    {
      "type": "Contribution",
      "agent": {
        "id": "CG-EX:Agent002",
        "type": "Agent",
        "label": "Noonan/Rasopathy WG (ClinGen)"
      },
      "contributionDate": "6/6/16 10:53 AM",
      "contributionRole": {
        "id": "SEPIO:0000154",
        "type": "ContributoryRole",
        "label": "assessor role"
      }
    }
  ],
  "description": "Variant is located in exon 15, which the RASopathy group has decided is an established functional domain for BRAF",
  "@context": "http://datamodel.clinicalgenome.org/interpretation/json/context"
}
